(Q33768927)

English

Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

C P Cannon

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1395-1402

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reocclusion: the flip side of coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse long-term effects of reocclusion after coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history and the effect of thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelets and thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiplatelet effects of ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet GPIIb-IIIa blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900364-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(99)00364-2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33768927&oldid=1534087892"